Clinical Outcomes In Real-World Patients with Long Lesions Receiving the XIENCE Everolimus-Eluting Stein (ILLS): One Year Results From the XIENCIV USA Study
Publication
, Conference
Hermiller, JB; Krucoff, MW; Mao, V; Zhao, W; Pechonkina, AV; Wang, J; Jonnavithula, L; Ruiledge, DR; Sudhir, K
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
September 21, 2010
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
September 21, 2010
Volume
56
Issue
13
Start / End Page
B67 / B67
Location
Washington, DC
Publisher
ELSEVIER SCIENCE INC
Conference Name
22nd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hermiller, J. B., Krucoff, M. W., Mao, V., Zhao, W., Pechonkina, A. V., Wang, J., … Sudhir, K. (2010). Clinical Outcomes In Real-World Patients with Long Lesions Receiving the XIENCE Everolimus-Eluting Stein (ILLS): One Year Results From the XIENCIV USA Study. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 56, pp. B67–B67). Washington, DC: ELSEVIER SCIENCE INC.
Hermiller, James B., Mitchell W. Krucoff, Vivian Mao, Weiying Zhao, Alena V. Pechonkina, Jin Wang, Lalitha Jonnavithula, David R. Ruiledge, and Krishnankutty Sudhir. “Clinical Outcomes In Real-World Patients with Long Lesions Receiving the XIENCE Everolimus-Eluting Stein (ILLS): One Year Results From the XIENCIV USA Study.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56:B67–B67. ELSEVIER SCIENCE INC, 2010.
Hermiller JB, Krucoff MW, Mao V, Zhao W, Pechonkina AV, Wang J, et al. Clinical Outcomes In Real-World Patients with Long Lesions Receiving the XIENCE Everolimus-Eluting Stein (ILLS): One Year Results From the XIENCIV USA Study. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2010. p. B67–B67.
Hermiller, James B., et al. “Clinical Outcomes In Real-World Patients with Long Lesions Receiving the XIENCE Everolimus-Eluting Stein (ILLS): One Year Results From the XIENCIV USA Study.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 56, no. 13, ELSEVIER SCIENCE INC, 2010, pp. B67–B67.
Hermiller JB, Krucoff MW, Mao V, Zhao W, Pechonkina AV, Wang J, Jonnavithula L, Ruiledge DR, Sudhir K. Clinical Outcomes In Real-World Patients with Long Lesions Receiving the XIENCE Everolimus-Eluting Stein (ILLS): One Year Results From the XIENCIV USA Study. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2010. p. B67–B67.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
September 21, 2010
Volume
56
Issue
13
Start / End Page
B67 / B67
Location
Washington, DC
Publisher
ELSEVIER SCIENCE INC
Conference Name
22nd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology